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Release of vasoactive amines from rabbit platelets has been implicated in a 
number of immunologic reactions in vivo (1). Studies in vitro have revealed im- 
munologic  release of histamine  and  serotonin  from platelets  by processes in- 
volving  immune  complexes  and  complement  (1-3)  and  immune  complexes, 
complement,  and  neutrophils  (4).  A  reaction which  occurs in  the  absence of 
complement or plasma has also been described, initially in rabbits infected with 
Shislosoma  mansoni  (5-7), but also in rabbits after immunization with protein 
antigens (1, 8-10). 
This  complement-independent  reaction  has  been  shown  to  require  blood 
leukocytes acting in the presence of antigen to induce release of histamine from 
platelets (1, 6, 8). In studies attempting to relate the mechanisms of release of 
vasoactive amines  to  the  deposition  of immune  complexes in  acute  immune 
complex disease (1, and manuscript in preparation), evidence was obtained that 
this latter reaction, requiring  antigen, leukocytes, and platelets, was involved. 
Studies  on  the  mechanism  of  the  leukocyte-dependent  release  of vasoactive 
amines from platelets are reported herein. 
Materials  and Methods 
Platdets.--The methods employed for harvesting and washing rabbit platelets have been 
described elsewhere (3) and essentially follow the method of Ardlie (personal communication 
from Dr. N. Ardlie, McMaster University, Hamilton, Canada). Adult New Zealand white 
rabbits were bled into acid citrate dextrose (ACD)  1 and platelets were obtained by differential 
* This is publication No. 368 from the Department  of Experimental Pathology, Scripps 
Clinic and  Research Foundation La Jolla, California 92037. The work was supported by 
United States Public Health Service Grant AI-07007. 
:~ Supported by United States Public Health Service  Training Grant 5 TI GM 683. 
1 Abbre~iations used in this paper: ACD, acid citrate dextrose; ADP, adenosine  diphosphate; 
AMP, adenosine monophosphate; ATP, adenosine triphosphate; B  SA, bovine serum albumin; 
DFP,  diisopropyl fluorophosphate; EDTA,  ethylenediaminetetraaeetate;  EGTA,  ethylene 
glycol tetraacetic acid; LDHR, leukocyte-dependent  histamine release; Mg EGTA, magnesium 
EGTA; MIF, macrophage migration inhibition factor; P, protein. 
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centrifugation. They were washed with Tyrode's solution containing 0.25% gelatin. Calcium 
was omitted from the first and second wash solution and  10  -4 z~ ethylene glycol tetraacetic 
acid (EGTA) was included in the first wash. In some experiments, ethylenediaminetetraacetate 
(EDTA) was used as the original anticoagulant. For work with platelets, siliconized glassware 
or plastic containers and pipettes were used throughout. 
Lenkocytes.--Rabbit blood was taken from the ear artery into 0.005 M EDTA. After light 
centrlfugation (400 g for 20  rain)  the platelet-rich plasma was removed. The layer of cells 
(platelets and leukocytes) on top of the erythrocytes was removed with a siliconized  Pasteur 
pipette with the tip bent at right agles. These cells were washed three times (300 g for 10 min) 
with the same Tyrode's solutions as used for the platelets and finally suspended in whole 
Tyrode's solution (containing Ca  ++) with gelatin. These preparations contained erythrocytes, 
but usually only a small percentage of granulocytes (5-10%). The majority of the leukocytes 
were mononuclear cells,  both large and small. 
For some experiments, such buffy coat cells were passed through columns of acid-washed, 
nonsiliconized  glass  beads  (No.  12  Ballotini,  Atlas  Chemical  &  Mfg.  Co.,  San  Diego, 
Calif.).  The columns were prepared in 10 ml plastic pipettes and 1-2 ml cells were allowed to 
run into the column in the Tyrode's solution with gelatin. After 30 mix at 37°C the nonadherent 
cells, including the erythrocytes, were eluted with the same diluent and then the adherent ceils 
were removed with Tyrode's solution containing 0.01 M EDTA. The cells were finally washed 
to  remove the EDTA. 
Spleen and lymph node cells were obtained by passing the organs through sieves in Tyrode's 
solution with 0.1  z~ EDTA sand washing the cell suspensions obtained. Bone marrow ceils 
came  from  the  femur.  Macrophages were washed  from  normal,  unstimulated  peritoneal 
cavities. The cells remaining after removal of platelet-rich plasma and the buffy coat layer 
contained most of the blood neutrophils and were either used as such, or the erythrocytes were 
sedimented with an equal volume of 2% gelatin. Thoracic duct lymphocytes were obtained by 
cannulation of rabbit thoracic duets, kindly performed by Dr. Sun Lee. All cells were washed 
and counted before testing. 
Immunization  of Rab~its.--Two  antigens were employed, bovine serum albumin  (BSA) 
(Armour Pharmaceutical Co., Chicago,  Ill.) and horse spleen ferritin (cadmium-free) (Nutri- 
tional Biochemicals Corp., Cleveland, Ohio). Rabbits with cells reactive to BSA were generally 
produced by an injection regimen identical to that used for acute immune complex disease 
(serum sickness).  It consisted of an intravenous injection of rabbit anti-BSA antiserum (5 #g 
antibody N/kg)  1 day before a large intravenous injection of BSA  (250 mg P  (protein)/kg). 
Other  injection  schedules  consisted  of  5  nag  BSA/kg  into  the footpads with  complete 
Freund's adjuvant or single injections (250, 100, 20, and 2 mg P BSA) intravenously without the 
previous antiserum. Subsequent injection courses comprised 250 mg or 20 mg BSA intraven- 
ously as a single injection. Ferritin was also injected intravenously as one dose (20 nag P/kg) 
Leukocyte-Dependent Rdease of Histamine (LDHR)  Test for  Screening of Rabbits.--This 
leukocyte-dependent histamine release test was used to examine rabbits for the presence of 
the reaction. The  total formed elements from 2  nil  blood taken  into 0.01 ~t EDTA  were 
washed three times with the Tyrode's solutions used for platelets. Two equal portions of the 
cells were taken and made to 2.5 ml with Tyrode's solution containing gelatin.  Antigen (62 
#g P BSA or 190 #g P ferritin) was added to one of the tubes and both were incubated for 30 
rain at 37°C. After centrifugation the supernatant was assayed for histamine. The percentage 
released was calculated after assay of the boiled sediments for their content of histamine. 
Reaction Conditions.--The reactions were performed in whole Tyrode's solution containing 
0.25% gelatin. Platelets (2.5 X  108) from normal rabbits, varying numbers of leukocytes and 
antigen were incubated in a total volume of 2.5 ml for 30 rain at 37°C. After centrifugation 
the supernate and sediments (boiled for 2 mln) were assayed for released materials. 
For examination of enzymes and nucleotides or electron microscopy, 5 X  109 platelets in p. M. I:IENSON  289 
a final volume of 5 ml and correspondingly increased quantities of leukocytes (2  X  107) and 
antigen (1.5 mg P ferritin) were used. The soluble factor was produced by incubation of buffy 
coat leukocytes (5)<  107 or more) with antigen (1.5  nag ferritin) for 20 rain at 37°C.  After 
centrifugation, the superuatant fuid containing the soluble factor was incubated with platelets. 
After the reaction was completed,  sedimented cells were lysed with two drops of  1 mg/ml 
Triton X 100 for enzymes, or boiled for histamine and serotonin. 
Assays.--Histamine and serotonin were assayed on the guinea pig ileum and estrous rat 
uterus, respectively, using appropriate standards. 
Acid phosphatase, lactic dehydrogenase,/3 glucuronidase, adenosine triphosphate (ATP), 
adenosine  diphosphate  (ADP),  and  adenosine  monophosphate  (AMP)  were  assayed  by 
standard procedures as described elsewhere  (3).  The samples were extracted with 4% per- 
chloric acid for the nucleotide assays. S6Rubidium was incorporated into the platelets before 
the reaction (11)  and both sediments and supernates were counted in a well-type counter to 
determine  the per  cent  released. 
Inhibitors.--Diisopropyl  fluorophosphate (DFP)  (Boots Pure Drug Co., Ltd., Nottingham, 
U.K.),  adenosine, and acetyl salicylate were prepared at 10 times the concentration used in 
saline and one-tenth volume was added to the tubes before the reactions. Mg EGTA  (mag- 
nesium EGTA) consisted of 0.005 M Na EGTA with 0.01 M MgC12. 2-deoxyglucose was used 
at 10  -3 M in a glucose-free environment, i.e., the cells were washed in, and the test performed in 
Tyrode's solution from which the glucose had been omitted. 
Electron Microscopy.--Platelets  to  be  used  for  electron  microscopic  examination  were 
prepared with ACD and at room temperature. Mter 15 min of reaction a portion was added to 
3 volumes of 3% ghitaraldehyde, pH 7.3, previously warmed to 37°C.  Mter 20 rain, the cells 
were centrifuged, fixed in osmic acid in the cold and embedded in Vestopal. Sections were cut, 
stained with uranyl acetate and lead citrate and examined in the Hitachi HUll microscope. 
RESULTS 
A  Test for the Release of Histamine from Platelets by Leukocytesfrom Sensitized 
Rabbits  Together with Antigen.--A  simple  test  was  devised for screening  of 
rabbits  for  the  presence  of  the  requisite  sensitized  leukocytes. The formed 
elements from 2 ml (or less) of whole blood were washed to remove the plasma, 
since antibody and complement could induce platelet histamine release by other 
mechanisms (3, 4). Incubation of antigen with the washed cells resulted in re- 
lease of histamine, the specificity of which could be determined by comparison 
with an identical tube lacking the antigen. Since most of the blood histamine 
in the rabbit is present in the platelets, the amount of histamine released was a 
rough guide to the strength  of the reaction, i.e.,  the  number and/or the re- 
activity of the leukocytes inducing release of histamine from the platelets. 
Presence of LDHR after Immunization  of Rabbits.--Fig. 1 shows the LDHR 
reaction in groups of rabbits immunized with BSA. The  reaction is expressed 
as the percentage of histamine released in the test described above. The primary 
injection course consisted of first an intravenous injection of anti-BSA antiserum 
(5 nag N/kg)  and then 250 mg BSA/kg 1 day later. This regimen is  also used 
to induce acute serum sickness (12), the lesions of which occur during  elimina- 
tion of antigen when antibody-antigen complexes are circulating. Immediately 
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of the rabbits. The reaction was still present, though weaker, in many rabbits 
after 22 days and some rabbits have shown it after 35  days. 
The second injection course comprised an intravenous injection of 250 mg/kg 
BSA given 2 months after the first course. The immune elimination of antigen 
was faster in such secondary reactions and the onset of the LDHR  was earlier 
and had disappeared faster than in the primary response. Some rabbits did not 
react to such high doses of BSA, either by immune elimination or by develop- 
ment  of  the  LDHR.  Ferritin  has  also  been  used  for  the  production  of  the 
LDHR  reaction.  Intravenous  injection of  20  mg/kg  resulted  in  a  more  con- 
sistent reaction which appeared earlier than with BSA (about the 7th day in a 
primary reaction). Lower doses of BSA, or BSA in adjuvant into the footpads 
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FIG. 1. Leukocyte dependent histamine release (LDHR) reaction in rabbits after immuniza- 
tion with BSA. The immunization  procedure is described  in the text. The use  of 131I-BSA 
permitted determination of the circulating antigen (12). The formed elements from 2 ml of 
blood taken at intervals after immunization were incubated for 30 rain at 37°C with and 
without antigen (62 #g P)  and the percentage of histamine released from the platelets was 
determined. 
did induce the LDHR,  but more variably, to a lesser degree, and for a  shorter 
duration. 
The Reaction of Buffy Coat Leukocytes, Antigen, and Platelets.--Fig. 2 depicts 
the  time course of the histamine release from  2.5  X  l0  s washed platelets in- 
duced by 2  X  10 ~ mononuclear leukocytes in a preparation of washed buffy coat 
cells from an immunized rabbit and 62 #g P  BSA. The histamine release com- 
menced after 2.5 rain and was complete after 10-15 rain of incubation at 37°C. 
Buffy coat leukocytes from a  nonimmunized rabbit were included as a  control 
and did not induce histamine release. 
The number of leukocytes required to produce the histamine release reaction 
varies from rabbit to rabbit and with the time of the immunization course. A 
representative titration  of mononuclear  cells in  the  buffy coat  from  a  single 
rabbit with constant antigen and platelets is shown in Fig. 3.50% release could 
have been produced witb about 5  X  105 leukocytes. P.  M.  HENSON  291 
The amount of antigen was varied in experiments shown in Table I. 5-10 #g 
BSA or ferritin induced only slight release of histamine from platelets in the 
presence of leukocytes. 30 #g or more induced maximal release with the leuko- 
cytes employed. Use of ferritin with leukocytes from rabbits immunized with 
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FIG. 2. Time course of leukocyte-dependent release of histamine from platelets. Buffy coat 
leukocytes (2  X  106) from a rabbit sensitized with BSA and from a normal animal were 
incubated at 37°C with 62 #g P BSA and 2.5 X  10  s platelets in a total volume of 2.5 ml. At 
intervals, tubes were removed and the reaction was stopped by cooling and the addition of 
EDTA (0.01 M). After centrifugation the percentage of histamine released from the platelets 
was determined. 
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FIO.  3. Titration of leukocytes. Increasing numbers of buffy coat cells (94% mononuclear 
cells) were incubated with antigen (62/zg BSA) and 2.5 X  10 s platelets for 30 min at 37°C. 
BSA or BSA with cells sensitized to ferritin did not lead to release of histamine 
from the platelets. 
The Ability  of Cells from Different  Sources to Participate  in the Leukocyte- 
Dependent Release of Histamine from Platelets.--Cells  from various lymphoid 
organs of rabbits which had  an active LDHR  reaction in the blood were ex- 
amined in the presence and absence of antigen for their effect on normal plate- 
lets.  The  results from  two  representative animals so  studied are  depicted  in 
Table  II.  The  number of  cells  which  induced 50%  histamine release  from 
2.5  X  l0  s platelets or the maximal nunlber tested is shown. 292  LEUKOCYTE-DEPENDENT  RELEASE  OF  VASOACTIVE  AMINES 
Cells from no other source approached the  activity of leukocytes from the 
blood. Release of 50 %  of histamine from the platelets could be obtained with 
spleen and bone marrow cells in the presence of antigen, but only if 1 or 2 )<  l0  s 
TABLE I 
Leukocyte-D@endentRdease  ~  Bistamineby DifferentQuantiti~ ~  Antigen* 
Ferritin  BSA 
P  Histamine released  P  Histamine released 
gg  %  ~g  % 
750  75  125  43 
30  75  31  43 
7.5  15  6  15 
3  11  1.6  8 
--  10  --  4 
*Buffy coat mononuclear leukocytes (2 X 106), platelets (2.5 X 108) and antigen were in- 
cubated for 30 min at 37°C. 
TABLE II 
The Number of Cells from Different Organs of a Sensitized Rabbit Required to Initiate Histamine 
Release from Platelets in the Presence of Antigen 
Source  of cells 
Rabbit immunized with ferritin  Rabbit immunized with BSA 
Number of  Number of  Histamine release  ceils  X  10  ~*  Histamine released  cells  X  10  ~ 
%  % 
Buffy coat  0.75  50  0.5  50 
Spleen  100  50  20  16 
Bone marrow  200  50  ND~  ND 
Mesenteric lymph node  200  25  20  0 
Popliteal lymph node  10  9  20  0 
Thoracic duct cells  ND  ND  100  0 
Peritoneal cells  2  4  20  0 
(macrophages) 
Peripheral neutrophils  2  0  ND  ND 
* The maximal number of cells tested, or the number required for 50% release of histamine 
from 2.5 X  10  s platelets in the presence of antigen (350/zg P ferritin or 62 #g P BSA). The 
results are representative of six similar experiments. 
ND, not done. 
cells  were  employed.  Cells  from  mesenteric  and  popliteal  lymph  nodes  oc- 
casionally showed some reactivity, but always required many more cells than 
from the blood. No activity could be found with thoracic duct lymphocytes ob- 
tained from four rabbits. Peritoneal macrophages, obtained without stimulation P. M.  n'ENSON  293 
of the peritoneal  cavity, did not show antigen-specific activity, although some 
histamine release (10-20%) did result from incubation of the maximal number 
tested  (2  X  10  e)  with  platelets  in the  absence  of  antigen.  To  examine  the 
possibility that lymphocytes were interacting with leukocytes in the blood to 
produce the effect on platelets,  mesenteric lymph node cells  (5  X  107) from a 
sensitized  rabbit were incubated with platelets  and buffy coat cells  (2  X  107) 
from a  normal  animal.  No  antigen-specific  release  of histamine  occurred,  al- 
though  30%  of  the  platelet  histamine  was  released  even  in  the  absence  of 
antigen. 
The preparation of buffy coat cells in the manner described usually contained 
10%  or less  granulocytes  (8%  in the  example  shown),  the  great  majority  of 
which were neutrophils. The remaining neutrophils were found below the buffy 
coat layer  and  when  tested  did  not  induce  histamine  release  from platelets. 
TABLE III 
The Adherence to Glass Bead Columns of Leukocytes Reacting with  Antigen  and Platelets* 
Number of leuocytes required for 50% histamine release from 2.5 X  108 platelets 
Whole huffy coat leukocytes  Nonadherent leukocytes  Adherent leukocytes 
10  5  5  X  10  6  10  5 
10  5  1.6  X  10 6  5  X  10  4 
3  X  10  ~  >2  X  10  6  3  X  10  5 
10 6  >2  X  10 6  5  X  10  5 
<5  X  10  5  >5  X  10 6  -- 
5  X  10  5  >5  X  10 6  -- 
<5  X  10  5  5  X  10  7  8  X  10  5 
<3  X  l0  s  >10  7  3  X  l0  t 
* The reaction conditions were those shown in Table II. 
Erythrocytes did not participate in the reaction, since they could be removed 
by hypotonic lysis and the remaining blood leukocytes were still active. 
Adherence of Reactive Cells to Glass Bead Columns.--Preparations  of reactive, 
washed buffy coat cells  were passed  through columns of glass beads.  The re- 
activity of the starting preparation,  the nonadherent cells, and the cells which 
were eluted from the column with EDTA were compared (Table III). It was 
found that the leukocytes which did not adhere to the column in the Tyrode's 
solution containing gelatin, which was used as a diluent,  were much less active 
in  inducing  histamine  release  from platelets  in  the  presence  of antigen  than 
either the starting preparation of cells or those eluted with EDTA. In general, 
10-100 times  as many nonadherent  cells  as whole buffy coat leukocytes were 
required  for  50%  histamine  release.  Adherent  cells  and  starting  bully  coat 
cells were about equally active with occasional increased (two-fold)  activity of 
the adherent cells. The numbers of cells shown are of mononuclear leukocytes. 
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buffy  coat were  eluted with  the EDTA  (0-5 %).  The  nonadherent  cells con- 
sisted largely of small lymphocytes when examined by light microscopy. Larger 
mononuclear  cells were  present  in  appreciable numbers  among  the  adherent 
cells, although the exact percentage varied and could not be accurately deter- 
mined  due  to  even  gradations  in  size,  amount  of cytoplasm,  etc.,  from that 
characteristic of small lymphocytes to that of large lymphoid cells. 
In  the  electron  microscope,  the  same  variation  was  seen.  Some  cells  re- 
sembled small lymphocytes with minimal cytoplasm, no vacuoles, granules, or 
endoplasmic reticulum  and  dense  chromatin  in  the  nucleus.  Others  had  the 
TABLE IV 
Decreasing Activity of Sensitized Leukocytes Incubated with Antigen* 
First incubation (leukocytes)  Second incubation (leukocytes 
and platelets)  Histamine release 
Time  Antigen  Time  Antigen 
min  min  % 
15  +  30  --  77 
30  +  30  --  62 
60  +  30  --  38 
120  +  30  --  26 
180  +  30  --  14 
180  +  30  +  19 
15  --  30  --  22 
180  --  30  --  18 
180  --  30  +  66 
* Leukocytes adherent to a glass bead column (See Materials and Methods section.) were 
incubated at 37°C with or without antigen (6 X  106 leukocytes +2.1 mg P ferritin). Portions 
containing 106 cells were removed at intervals, washed,  and incubated for a further 30 min 
with or without antigen (350 #g P) in the presence of 5 X  l0  s platelets. The percentage of 
histamine released from the platelets was then determined. 
appearance of monocytes, a larger cytoplasm containing endoplasmic reticulum, 
golgi apparatus,  vacuoles,  and  sometimes granules,  as well.  Other  cells were 
intermediate between these extremes. 
The Effect of Pretreatment  of Leukocytes  with Antigen on  Their Reaction with 
Platelets.--In  order  to  examine  the  ability of  the  leukocytes  to  react  with 
platelets following an initial exposure to antigen (7)  the following experiments 
were performed. 
Leukocytes  from  a  rabbit  immunized  with  ferritin  were  incubated  with 
ferritin for increasing lengths of time. They were centrifuged, resuspended, and 
added to platelets without  additional antigen. Such cells did induce release of 
histamine from platelets, but the release diminished with the time of preincu- 
bation of the leukocytes with antigen (Table IV). After 3 hr, the cells induced P.  M.  HENSON  295 
only 14 % release, i.e., showed loss of activity. Addition of antigen during incu- 
bation  of these  "exhausted"  cells  with  platelets  did  not  restore  the  activity. 
However, leukocytes incubated without  antigen for 3  hr did induce release  of 
histamine when added to platelets and antigen, showing that activity could be 
retained over this time period at 37°C in the absence of antigen. 
This "exhaustive" effect of antigen on the leukocytes was shown in another 
way (Table V). Leukocytes were preincubated with antigen for 20 min, washed, 
and  then  incubated  with  platelets  either  with  or without  additional  antigen. 
Leukocytes  preincubated  with  antigen  did  induce  release  of histamine  from 
platelets after washing without additional antigen (60%), although the amount 
TABLE V 
Inhibitory  Effect~Antigenon Sensitized Leukocytes Which HaveBeen PreexposedtoAntigen* 
First incubation (leukocytes)  Second incubation (leukocytes 
and platelets)  Histamine release 
Time  Antigen  EDTA (10-2~)  Time  Antigen 
min  min  % 
--  --  --  30  +  70 
20  +  --  30  --  60 
20  +  --  30  +  40 
20  -}-  +  30  --  32 
20  +  +  30  +  24 
20  --  --  30  --  22 
20  --  --  30  +  65 
20  --  +  30  -  22 
20  --  +  30  +  66 
* Buffy coat leukocytes (106) were incubated  for 20 min at 37°C with or without antigen 
(62 #g P BSA) and with or without EDTA (0.01 M). After washing, they were incubated  for 
a further 30 rain with or without antigen (31 #g P)  in the presence of 2.5 X  108 platelets. The 
percentage of histamine released from the platelets was then determined. 
was less  than  if  platelets,  leukocytes,  and  antigen  were  all  reacted  together 
(70%). If, however, antigen was included in the second incubation, i.e., during 
the reaction with platelets, less histamine release occurred (40 %). These effects 
could be accentuated by performing the preincubation of antigen and leukocytes 
in  the  presence  of 0.01  M EDTA.  Such leukocytes  now  reacted  poorly with 
platelets  after  washing  (32 %  release),  and  if  antigen  was present  during  the 
second incubation,  the  histamine  release  was even lower  and  approached  the 
background level. Controls consisted of leukocytes preincubated in the absence 
of  antigen  and  these  were  shown  to  be  narmally  reactive  with  antigen  and 
platelets  after washing. 
The results indicated that preincubation  of leukocytes with antigen reduced 
their ability to react with antigen and platelets and that the presence of EDTA 296  LEUKOCYTE-DEPENDENT  RELEASE  OF VASOACTIVE AMINES 
during the preincubation increased the inhibition. Omission of glucose from the 
preincubation reaction or, to a  lesser extent, performing it in the cold, had the 
same effect as EDTA,  i.e., increased the inhibitory effect of the preincubation. 
The results also confirm that leukocytes reacted with antigen and washed can 
still induce release of histamine from platelets, though they are not as active as 
if all three reactants were incubated together. 
The Production of a Soluble Factor from the Leukocytes.--A possible mechanism 
for the LDHR  reaction could involve the release of a  material from the leuko- 
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FIG. 4. Release  of a soluble factor from leukocytes measured by its effect (release of hista- 
mine) on platelets. Buffy coat leukocytes (5 X  106) from normal rabbits or those sensitized 
with ferritin or BSA were incubated with antigen (700 #g P  ferritin or 125 #g P  BSA). At 
intervals the cells were  sedimented and the supernatant fluid (containing releasing  factors) 
was  incubated with 2.5  X  10  s platelets for 30 min. at 37°C. The percentage of histamine 
released  from the platelets was then determined. 
cytes which would cause platelets  to release their histamine. Experiments de- 
scribed in Fig. 4  demonstrated such a  substance. 
Antigen (BSA or ferritin) was incubated with buffy coat leukocytes from appropriately 
immunized rabbits. After varying intervals, the cells were  centrifuged and the supernatant 
was incubated with platelets for 30 min at 37°C. The per cent release of histamine from the 
platelets was assayed by determination of the levels in the fluid and in the sedimented platelets 
after the incubation  period.  Since the huffy coat usually contained a few platelets, some hista- 
mine was already present in the supernatants used, and these values were subtracted from the 
amount found after the final incubation with platelets so that the quantity released  by the 
platelets could be determined. The finding of less histamine remaining in the platelets after 
the incubation served to confirm the releasing effect. 
Fig. 4  shows that with both ferritin and BSA  as antigen a  soluble releasing 
factor was liberated from leukocytes within 2-5 min of incubation. It was not 
produced in the absence of antigen or with a different antigen. Moreover, incu- 
bation of antigen and buffy coat cells from a normal rabbit did not yield such a P.  ~.  n~NSON  297 
factor. Omission of glucose from the incubation step of antigen with leukocytes 
resulted in reduced and delayed production of the releasing factor. 
The soluble factor from the leukocytes was found to be considerably labile. 
Storage at different temperatures, freezing, or lyophilization have resulted in 
varying, but usually low, recoveries. Attempts to characterize the factor by 
dialysis, passage through filters or through gel columns have likewise yielded 
variable recoveries. Consequently, the experiments on the soluble factor that 
are reported herein were performed soon after sedimentation of the leukocytes 
so that loss of activity was minimized. 
Inhibition of the Production o/the Soluble Factor and of its Effect on Platelets.-- 
A number of inhibitors or inhibiting conditions which have been used for study 
of reactions resulting in release of materials from platelets were examined for 
their effect on the leukocyte-dependent reaction. Fig. 5 shows the effect of the 
inhibitors on the production of soluble factor by the leukocytes. The leukocytes 
were incubated with antigen and inhibitor in a small volume, so that when 0.25 
ml of the supernatant was transferred to 2.25 ml of diluent containing platelets, 
the  inhibitors  were  diluted  1:10.  As  controls,  inhibitors diluted  1:10  were 
checked in the reaction of soluble factor with platelets, so that the inhibitory 
effect on the production of the soluble factor could be determined. 
If the glucose in the Tyrode's solution was replaced with 10  -3 ~  2-deoxy- 
glucose,  an inhibitor of glucose metabolism, less  soluble factor  (as  measured 
by histamine release from platelets) was produced. Mg EGTA was completely 
inhibitory  and  acetyl  salicylate  partially  so.  Adenosine,  however,  did  not 
diminish the amount of soluble factor produced. DFP produced an anomalous 
effect, since  treatment of the leukocytes with DFP  even in  the  absence  of 
antigen caused the supernatant material to release 79 % histamine from plate- 
lets. In a similar way, pretreatment of the leukocytes with DFP has also yielded 
antigen-independent,  histamine-releasing  activity,  although  the  presence  of 
DFP during the reaction of platelets, leukocytes, and antigen is inhibitory. 
Fig. 5 also depicts the effect of the inhibitors on the whole reaction of antigen, 
leukocytes, and platelets incubated together. 2-deoxyglucose replacing glucose 
was markedly inhibitory and Mg EGTA  abolished the reaction completely. 
DFP, acetyl salicylate, and adenosine also inhibited the reaction, but to a lesser 
extent. 
The effect of the soluble factor on platelets was also examined with similar 
effects. All  five materials  were  inhibitory,  acetyl salicylate being  the  least 
effective. 
The Effect  of the Reaction on Platelet Morphology.--Platelets  undergoing the 
reaction with leukocytes and antigen or with the soluble factor were examined 
after  15  min of incubation by electron microscopy (Figs.  7  and 8).  In both 
situations loose dumps of platelets were seen,  often consisting of only a  few 
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interdigitating processes, and in many, the granules and canalicular system had 
disappeared, h  other platelets near the outside of the clump,  these organelles 
were concentrated in the center of the cell in  a  basket-like network  of micro- 
tubules.  Platelet lysis was  not  seen.  Platelets  treated  with  supernatant  from 
leukocytes  incubated  without  antigen  showed  few  clumps  and  only  slight 
changes, consisting of some grouping of intraceliular granules and canalicnli in 
FIG. 5.  The  effect  of  inhibitors on  the leukocyte-dependent  release  of histamine from 
platelets. Inhibition of the whole reaction was  achieved  by including  the inhibitors in the 
reaction with sensitized buffy coat leukocytes  (3)<  106), antigen (62 #g P BSA) and platelets 
(2.5 ;<  10s). Incubation of the inhibitors, antigen,  and leukocytes for 20 rain at 37°C in a 
volume of 0.25 ml with subsequent  addition of the supernatant fluid to platelets was used to 
show inhibition of production of the soluble factor. Soluble factor was also produced from the 
buffy coat leukocytes in bulk (in the proportions of cells and antigen noted above) and then 
incubated with platelets in the presence of the inhibitors. 
the  center  of  the  cells.  In  the  reaction  with  buffy  coat leukocytes, only oc- 
casionally were leukocytes seen in the platelet clumps,  and then, generally at 
the edge. In nearly every case, the leukocytes thus involved contained extensive 
cytoplasm with some vacuoles and granules. 
Release of Platelet Constiluenls.--Since,  morphologically, the reaction did not 
appear to result in platelet cytolysis and since a requirement for platelet energy 
(glucose)  was  shown,  the  process may  require  an  active participation of  the 
platelet. Accordingly, a variety of platelet constituents was examined to deter- 
mine what types of substances were released. Since the reaction is complex, the 
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released from the leukocytes or contained in the source of soluble factor have 
been subtracted.  Representative  control  values  (release from platelets  alone) 
and  total levels within  5  X  10  9 platelets  have been described  elsewhere  (3). 
Fig.  6  shows  some  representative  results.  Histamine  and  serotonin  behaved 
alike and were released to the greatest degree.  Nucleotides  (ATP, ADP,  and 
AMP)  were not  released in great  quantity  over and above that  found in  the 
controls, although the degree of metabolism of any released nucleotides during 
the reaction was not determined. S~Rubidium was incorporated into the platelets 
and its release is an indication  of potassium loss. Levels only slightly greater 
than  the  control  values were found.  The  intracytoplasmic enzyme lactic  de- 
hydrogenase was not released. Of the two lysosomal enzymes, acid phosphatase 
/~-glucuronidase, only a very low level of the latter was liberated. 
FIG. 6. Release of platelet constitutents by the leukocyte-dependent  reaction. The reactions 
were performed as described in the Materials and Methods section. The results are representa- 
tive  of four similar experiments. 
DISCUSSION 
Incubation  of  antigen,  blood  leukocytes  from  an  immunized  rabbit  and 
rabbit platelets results in release of vasoactive amines from the platelets. This 
process,  unlike  other  immunologic  reactions  of  rabbit  platelets  leading  to 
vasoactive amine release (3, 4),  did not  apparently require complement, since 
thoroughly  washed  leukocytes  and  platelets  could  be  employed.  Moreover, 
rabbits depleted of C3 with cobra venom factor were still capable of exhibiting 
the leukocyte-dependent histamine release reaction in the blood after immuniza- 
tion (1,  and manuscript in preparation). 
Presence  of the Reaction  in the Blood  after  [mmunization.--In  the present studies, 
BSA  or ferritin was used as antigen and the animals were immunized by the intra- 
venous route. A large injection of BSA was found most efficacious, but smaller quanti- 
ties sufficed if ferritin was employed. The reaction was detected by incubating antigen 
with whole washed blood cells and determining the  quantity  of histamine released. 
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cannot be excluded, but since most of the blood histamine in the rabbit is contained 
within the platelets (13), the procedure served as a useful screening test for the pres- 
ence of the LDHR reaction in rabbit blood. After injection of BSA, the reaction could 
be elicited (i.e., reactive leukocytes were present in the blood) after the circulating 
antigen had been eliminated. Before that time, even if the leukocytes were present, 
they would presumably have already reacted with antigen and thus be undetectable. 
After a primary injection the reaction persisted for from 3-5 wk. After a second or sub- 
sequent  injection  of  BSA,  however,  the  reaction was  detectable earlier  (reflecting 
earlier antigen elimination) and disappeared more quickly. Rabbits which did not give 
immune elimination of the antigen (tolerant animals) did not exhibit the reaction in the 
blood. It appeared, therefore,  that  the  time when  the reactive leukocytes could be 
detected in the blood corresponded with the time of most active antibody synthesis. 
The Nature  of the  Participating Leukocytes.--The  type of leukocyte which reacts 
with antigen and platelets, resulting in histamine release, was partially purified from 
the blood in an attempt to identity it. Since the most reactive preparation contained 
less than  10%  grannlocytes and, moreover, blood granulocytes by themselves were 
inactive, mononuclear  cells were  implicated.  Schoenbechler  and  Barbaro  (6)  have 
suggested that the cell is a small lymphocyte. However, in our hands the reactive leu- 
kocytes did not pass through columns of glass beads but remained adherent and could 
then be eluted off with EDTA. The cells were examined by electron microscopy, but in 
the absence of any evidence to date concerning the reactivity of individual cells, it is 
impossible to determine the cell type involved. The morphology of the adherent leuko- 
cytes varied from  that corresponding to the small lymphocyte to that more closely 
resembling the monocyte. Many of the cells had somewhat scattered chromatin and 
relatively extensive cytoplasm with occasional vacuoles. In an examination of reactions 
with platelets, the only cell types seen regularly associated with platelet clumps were 
cells with granules and vacuoles. However, this association was not common, and it was 
felt unlikely to lead directly to such extensive release of histamine. 
The blood was the best source of leukocytes which could participate in this reaction. 
The inactivity of thoracic duct cells and lymph node cells again suggested that the 
general circulating pool of small lymphocytes was not involved. At the time of greatest 
activity in the blood, other parts of the body appeared to be relatively deficient in 
reactive cells. However, examination of lymphoid organs at times later in the immuni- 
zation might reveal a  somewhat different pattern. The possibility that  "sensitized" 
lymphocytes were reacting with cells such as monocytes in the blood and then inducing 
histamine release from platelets was felt to be unlikely since lymph node cells from an 
immunized rabbit did not confer reactivity upon buffy coat leukocytes from a normal 
rabbit. It has been suggested that homocytotropic antibody may be involved in this 
release of vasoactive amines from platelets (15)  and indeed some correlation of homo- 
cytotropic antibody production and the presence of the leukocyte-dependent release 
reaction in the blood has been found (10). However, attempts to passively sensitize 
blood leukocytes from a  normal rabbit with plasma or serum from sensitized rabbits 
with or without homocytotropic antibody have consistently met with failure. Despite 
this, the possibility that  the blood leukocytes have passively absorbed antibody on 
their surfaces cannot yet be excluded. 
The Production  of a  Soluble  Factor from the Leukocytes.--The  release of a  soluble P.  M.  HENSON  301 
factor from the leukocytes, capable of acting on platelets, was suggested by the small 
numbers of leukocytes required. A ratio of 1 leukocyte to 1000 or more platelets has 
been frequently observed and the actual ratio may be very much higher, since the pro- 
portion of active ceils in the leukocyte preparation was not known. The possibility also 
exists that the leukocytes may contact many platelets for a brief period, thereby lead- 
ing to release of histamine. However, this was felt to be unlikely as a complete explana.- 
tion, since platelet dumping and release occur very quickly. In addition, association of 
leukocytes with the platelets was not regularly seen, and occurred just as frequently 
when antigen was omitted as when it was present. 
A search for a soluble agent was therefore pursued and resulted in demonstration of 
the  release of  such  a  substance  from  the  leukocytes. Addition of  the  supernatant 
medium from the reaction of antigen with reactive leukocytes to normal rabbit plate- 
lets resulted in release of vasoactive amines. The soluble factor was easily lost, how- 
ever, and its lability may account for earlier reports of its absence, (7) and have pre- 
vented, as yet, its characterization. It appears to be released from leukocytes by an 
active process which may be inhibited in the cold or by chelation of calcium. Its libera- 
tion depends upon the presence of specific antigen and proceeds within 2 min of addi- 
tion of the antigen. 
The Effect of the Reaction on the Platelets.--The effect of the soluble factor, or of the 
leukocytes and antigen upon the platelets was similar. The release of histamine and 
serotonin was not accompanied by release of intracellular enzymes or by large amounts 
of rubidium. A  nonlytic process was thus suggested and was confirmed morphologi- 
cally. The platelets formed loose dumps and exhibited some of the changes (disappear- 
ance of granules and canaliculi) described for other active, immunologic release mecha- 
nisms  (3,  4),  but no lysis was observed. Active participation of the platelet in the 
release of the vasoactive amines was also indicated by the requirement for glucose, 
esterases,  and  environmental  calcium  and  by  the  inhibitory  action  of  aspirin 
and adenosine. It was of interest that while aspirin was inhibitory to both the release of 
soluble factor from the leukocytes and release of vasoactive amines from the platelets, 
adenosine had an effect only on the latter process. 
The Possible  Rdationship of the Reaction  to Those Involving Release of Factors from 
Lymphocytes.--Cytotoxic factors (16-18), chemotactic agents (19, 20)  and substances 
inhibitory to macrophage migration (MIF)  (21, 22)  are liberated from lymphocytes 
and the platelet-releasing  factor may be related to them. However, in contrast to these 
materials,  the platelet-releasing factor was produced by blood leukocytes and  was 
released immediately after contact with antigen. Moreover, the releasing factor was not 
cytotoxic to the platelets, but this may be an effect of the dose level. Preliminary 
studies  with  gel  filtration  have  suggested  a  size  for  the  releasing  factor  similar 
to lymphotoxin and MIF. One possibility that is at present under investigation is that 
the leukocytes in the blood are lymphocytes already "transformed"  by  the  antigen 
(injected intravenously) and that subsequent addition of antigen serves to cause re- 
lease and/or synthesis and release of the factor which acts on platelets and which may 
or may not be related to the other lymphocyte factors. Another possible explanation 
for the activity of supernatants from leukocytes incubated with antigen could be the 
presence of ADP,  which is known  to induce platelet dumping and some release of 
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leukocytes incubated  with  antigen  when  compared  to  those  without  antigen,  and 
equivalent quantities of ADP added to platelets did not induce a comparable amount 
of vasoactive amine release.  Consequently, although ADP may contribute to the reac- 
tion, it did not appear to be the only factor involved. 
The reaction of antigen with leukocytes in the presence of platelets resulted in the 
greatest  release  of  vasoactive  amines.  Moreover,  as  reported  by  Barbaro  and 
Schoenbechler (7),  incubation of leukocytes which were previously treated with anti- 
gen and  then  washed  still  induced histamine  release.  In contrast  to their  findings, 
however, the amount of release  decreased with increasing time of pretreatment of the 
leukocytes with antigen. This suggested either an exhaustion of the cells, perhaps due 
to release  of all their soluble factor, or inactivation by prolonged contact with antigen. 
Contact of the leukocytes with antigen under conditions where soluble  factor release 
did not occur (4°C or with EDTA), followed by washing, yielded leukocytes which were 
much less active when incubated with platelets and additional antigen. This may rep- 
resent  decay of activities in the membrane, responsible for release  of the soluble fac- 
tor, and if so it may open up an approach to the study of this release  process. This 
effect could account for the inability to detect the LDHR during the presence of anti- 
gen in the circulation (Fig. 1) although clearance of cells which have already reacted 
with antigen may also occur. 
Involvement of the Reaction in Acute Immune Complex Disease.--The  release  of vaso- 
active amines from platelets by this reaction with antigen and leukocytes has been 
implicated in the pathogenesis  of acute immune complex disease  in rabbits  (1,  and 
manuscript in preparation). The deposition of immune complexes in blood vessel walls 
and in the glomerulus involves an increase in vascular permeability apparently induced 
by vasoactive amine release  from platelets  (23).  Since  complement depletion was not 
inhibitory  to  this  process  (1),  the  complement-dependent histamine  release  mecha- 
nisms (3, 4)  did not appear to be involved, suggesting that the leukocyte-dependent 
process might be required. Correlation of the presence of the leukocyte-dependent re- 
action in the blood and  the occurrence of lesions  of acute immune complex disease 
(1, 10) provided additional evidence of its involvement. 
SUi~MARY 
The immunological  release  of vasoactive amines from rabbit  platelets  by a 
mechanism  requiring  blood  leukocytes  has  been  described.  The  reaction  in- 
volved leukocytes from an immunized rabbit, antigen, and platelets and did not 
require  the complement system.  The leukocytes appeared to be mononuclear, 
had the  ability  to adhere  to glass,  and were found in greater  numbers  in the 
blood  than  in spleen,  lymph  nodes,  thoracic  duct  lymph,  bone marrow,  and 
peritoneal cavity washings. 
Part or all of the effect on the platelets appeared to result from active release 
of a soluble factor from the leukocytes, which induced vasoactive amine release 
from the  platelets.  The platelets  were  not lysed during  this  reaction  and  the 
release  of  vasoactive  amines  required  the  active  participation  of  metabolic 
pathways in the platelet. P.  M.  HENSON  303 
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hydrodynamic forces. J. Exp. Med. 127:119. FIG. 7.  Morphology of platelets incubated with soluble factor. (a) factor from nor- 
mal leukocytes; (b) factor from sensitized leukocytes. The supernatant fluid from the 
reactions of buffy coat leukocytes and antigen (See Materials and Methods section.) 
was incubated with 2.5  X  109 platelets for 15 rain before fixation in glutaraldehyde at 
37°C. The soluble factor from sensitized leukocytes induced loose dumps of platelets 
and disappearance of granules and canaliculi. The supernatant fluid from normal leuko- 
cytes caused less change in the platelets (loss of regular discoid shape and  some clus- 
tering of organelles in the center of the ceils). X  28,000. 
305 FIG. 8.  Morphology of platelets undergoing leukocyte dependent release of hista- 
mine. Buffy coat leukocytes (2  ×  10v), antigen (620 #g P  BSA) and platelets (2.5  X 
109) were incubated together for 15 min at 37°C before glutaraldehyde fixation. Loose 
clumps of platelets are apparent with some disappearance of granules and canaliculi. X 
30,000. 
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